The U.S. health regulator on Wednesday approved Ferring Pharmaceuticals' fecal transplant-based therapy to reduce the recurrence of a bacterial infection, making it the first therapy of its kind to be cleared in the country.
Japan's Eisai Co plans to seek full approval of its experimental Alzheimer's drug lecanemab in the United States, Europe and Japan armed with data showing it can slow the brain-wasting disease for people with early symptoms, potentially getting the treatment to patients next year.
Indiana's attorney general on Wednesday asked the state's medical board to discipline an Indiana doctor who performed an abortion on a 10-year-old rape victim from Ohio in a case that became a flashpoint in the debate over access to the procedure.
Eli Lilly and Co's COVID-19 drug bebtelovimab is not currently authorized for emergency use in the United States, the Food and Drug Administration said, citing it is not expected to neutralize the dominant BQ.1 and BQ.1.1 subvariants of Omicron.
The U.S. Centers for Disease Control and Prevention (CDC) said on Wednesday it will expand wastewater testing for poliovirus in areas with low vaccination coverage or counties that are linked to a case in New York reported in July.
The giant Chinese cities of Guangzhou and Chongqing announced an easing of COVID curbs on Wednesday, a day after demonstrators in southern Guangzhou clashed with police amid a string of protests against the world's toughest coronavirus restrictions.
Corteva Inc will buy biologicals firm Stoller Group Inc for $1.2 billion in cash, the companies said on Wednesday, as it looks to expand its crop protection business.
Johnson & Johnson's Janssen unit has sued Amgen Inc over its plan to market a drug for ulcerative colitis and other conditions similar to J&J's top-selling Stelara, saying it would infringe two patents in a lawsuit made public on Wednesday.
Britain's health service faces further disruption in December after thousands of ambulance workers represented by three different trade unions voted for strike action in disputes over pay and conditions.
The number of people in Europe with undiagnosed HIV has risen as testing rates fell during the COVID-19 pandemic, threatening a global goal of ending the disease by 2030, a report said.
